世界のロムスチン市場レポート2020年

QYResearchが発行した調査報告書(QYR20ST06913)
◆英語タイトル:Global Lomustine (CAS 13010-47-4) Sales Market Report 2020
◆商品コード:QYR20ST06913
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年9月(※2024年版があります。お問い合わせください。)
◆ページ数:135
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、北米、ヨーロッパ、日本、アジアなど
◆産業分野:医薬品、医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥888,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

QYリサーチ社の本調査レポートでは、世界のロムスチン市場について種類別(10mg/錠剤、40mg/錠剤、100mg/錠剤)、用途別(病院薬局、小売薬局、オンライン薬局)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・ロムスチン市場の概要
・世界の主要地域別ロムスチン市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のロムスチン市場規模2015-2026:種類別(10mg/錠剤、40mg/錠剤、100mg/錠剤)
・世界のロムスチン市場規模2015-2026:用途別(病院薬局、小売薬局、オンライン薬局)
・ロムスチンの北米市場規模2015-2020
・ロムスチンのヨーロッパ市場規模2015-2020
・ロムスチンの中国市場規模2015-2020
・ロムスチンの日本市場規模2015-2020
・ロムスチンの東南アジア市場規模2015-2020
・ロムスチンのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・ロムスチンの製造コスト分析
・販売チャネル、流通業者、顧客
・ロムスチンの市場動向・機会・課題
・調査の結論
【レポートの概要】

A recently published report by QY Research titled Global Lomustine (CAS 13010-47-4) Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Lomustine (CAS 13010-47-4) market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Lomustine (CAS 13010-47-4), C9H16ClN3O2, the formula weight is 233.7, and its form is yellow crystal powder.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Lomustine (CAS 13010-47-4) market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Lomustine (CAS 13010-47-4) industry.
Based on our recent survey, we have several different scenarios about the Lomustine (CAS 13010-47-4) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Lomustine (CAS 13010-47-4) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Lomustine (CAS 13010-47-4) market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Lomustine (CAS 13010-47-4) market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Lomustine (CAS 13010-47-4) market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Lomustine (CAS 13010-47-4) market. The report also includes nautical information, where it shows Lomustine (CAS 13010-47-4) market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Lomustine (CAS 13010-47-4) market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Lomustine (CAS 13010-47-4) market.
Lomustine is an alkylating agent antitumor drug. It is fat-soluble and can enter the cerebrospinal fluid through the blood-brain barrier. It is commonly used in primary brain tumors and secondary tumors. It can treat solid tumors such as gastric cancer and rectal cancer. Bronchial lung cancer, malignant lymphoma.
Geographical Analysis:
Based on region, the global Lomustine (CAS 13010-47-4) market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Lomustine (CAS 13010-47-4) market are
Medicon Pharma
Nanjing Pharma
Bristol-Myers Squibb
NextSource Pharma
Zhongfu Pharma
Miracalus Pharma
ACTIZA
Ther Dose
Segment by Type
10mg/Tablet
40mg/Tablet
100mg/Tablet
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Lomustine (CAS 13010-47-4) market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Lomustine (CAS 13010-47-4) market.
• The market share of the global Lomustine (CAS 13010-47-4) market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Lomustine (CAS 13010-47-4) market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Lomustine (CAS 13010-47-4) market.

【レポートの目次】

1 Lomustine (CAS 13010-47-4) Market Overview
1.1 Lomustine (CAS 13010-47-4) Product Scope
1.2 Lomustine (CAS 13010-47-4) Segment by Type
1.2.1 Global Lomustine (CAS 13010-47-4) Sales by Type (2020-2026)
1.2.2 10mg/Tablet
1.2.3 40mg/Tablet
1.2.4 100mg/Tablet
1.3 Lomustine (CAS 13010-47-4) Segment by Application
1.3.1 Global Lomustine (CAS 13010-47-4) Sales Comparison by Application (2020-2026)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Lomustine (CAS 13010-47-4) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Lomustine (CAS 13010-47-4) Sales Growth Rate (2015-2026)
1.4.2 Global Lomustine (CAS 13010-47-4) Revenue and Growth Rate (2015-2026)
1.4.3 Global Lomustine (CAS 13010-47-4) Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Lomustine (CAS 13010-47-4) Industry Impact
1.5.1 How the Covid-19 is Affecting the Lomustine (CAS 13010-47-4) Industry
1.5.1.1 Lomustine (CAS 13010-47-4) Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Lomustine (CAS 13010-47-4) Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Lomustine (CAS 13010-47-4) Players to Combat Covid-19 Impact

2 Lomustine (CAS 13010-47-4) Estimate and Forecast by Region
2.1 Global Lomustine (CAS 13010-47-4) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Lomustine (CAS 13010-47-4) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Lomustine (CAS 13010-47-4) Sales Market Share by Region (2015-2020)
2.2.2 Global Lomustine (CAS 13010-47-4) Revenue Market Share by Region (2015-2020)
2.3 Global Lomustine (CAS 13010-47-4) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Lomustine (CAS 13010-47-4) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Lomustine (CAS 13010-47-4) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Lomustine (CAS 13010-47-4) Estimates and Projections (2015-2026)
2.4.2 Europe Lomustine (CAS 13010-47-4) Estimates and Projections (2015-2026)
2.4.3 China Lomustine (CAS 13010-47-4) Estimates and Projections (2015-2026)
2.4.4 Japan Lomustine (CAS 13010-47-4) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Lomustine (CAS 13010-47-4) Estimates and Projections (2015-2026)
2.4.6 India Lomustine (CAS 13010-47-4) Estimates and Projections (2015-2026)
3 Global Lomustine (CAS 13010-47-4) Competition Landscape by Players
3.1 Global Top Lomustine (CAS 13010-47-4) Players by Sales (2015-2020)
3.2 Global Top Lomustine (CAS 13010-47-4) Players by Revenue (2015-2020)
3.3 Global Lomustine (CAS 13010-47-4) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lomustine (CAS 13010-47-4) as of 2019)
3.4 Global Lomustine (CAS 13010-47-4) Average Price by Company (2015-2020)
3.5 Manufacturers Lomustine (CAS 13010-47-4) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Lomustine (CAS 13010-47-4) Players (Opinion Leaders)
4 Global Lomustine (CAS 13010-47-4) Market Size by Type
4.1 Global Lomustine (CAS 13010-47-4) Historic Market Review by Type (2015-2020)
4.1.1 Global Lomustine (CAS 13010-47-4) Sales Market Share by Type (2015-2020)
4.1.2 Global Lomustine (CAS 13010-47-4) Revenue Market Share by Type (2015-2020)
4.1.3 Global Lomustine (CAS 13010-47-4) Price by Type (2014-2020)
4.2 Global Lomustine (CAS 13010-47-4) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Lomustine (CAS 13010-47-4) Sales Forecast by Type (2021-2026)
4.2.2 Global Lomustine (CAS 13010-47-4) Revenue Forecast by Type (2021-2026)
4.2.3 Global Lomustine (CAS 13010-47-4) Price Forecast by Type (2021-2026)
5 Global Lomustine (CAS 13010-47-4) Market Size by Application
5.1 Global Lomustine (CAS 13010-47-4) Historic Market Review by Application (2015-2020)
5.1.1 Global Lomustine (CAS 13010-47-4) Sales Market Share by Application (2015-2020)
5.1.2 Global Lomustine (CAS 13010-47-4) Revenue Market Share by Application (2015-2020)
5.1.3 Global Lomustine (CAS 13010-47-4) Price by Application (2015-2020)
5.2 Global Lomustine (CAS 13010-47-4) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Lomustine (CAS 13010-47-4) Sales Forecast by Application (2021-2026)
5.2.2 Global Lomustine (CAS 13010-47-4) Revenue Forecast by Application (2021-2026)
5.2.3 Global Lomustine (CAS 13010-47-4) Price Forecast by Application (2021-2026)

3 North America Lomustine (CAS 13010-47-4) Market Facts & Figures
3.2 North America Lomustine (CAS 13010-47-4) Sales Market Share by Company (2015-2020)
3.3 North America Lomustine (CAS 13010-47-4) Sales Market Share by Type (2015-2020)
3.4 North America Lomustine (CAS 13010-47-4) Sales Market Share by Application (2015-2020)

4 Europe Lomustine (CAS 13010-47-4) Market Facts & Figures
4.2 Europe Lomustine (CAS 13010-47-4) Sales Market Share by Company (2015-2020)
4.3 Europe Lomustine (CAS 13010-47-4) Sales Market Share by Type (2015-2020)
4.4 Europe Lomustine (CAS 13010-47-4) Sales Market Share by Application (2015-2020)

5 China Lomustine (CAS 13010-47-4) Market Facts & Figures
5.2 China Lomustine (CAS 13010-47-4) Sales Market Share by Company (2015-2020)
5.3 China Lomustine (CAS 13010-47-4) Sales Market Share by Type (2015-2020)
5.4 China Lomustine (CAS 13010-47-4) Sales Market Share by Application (2015-2020)

6 Japan Lomustine (CAS 13010-47-4) Market Facts & Figures
6.2 Japan Lomustine (CAS 13010-47-4) Sales Market Share by Company (2015-2020)
6.3 Japan Lomustine (CAS 13010-47-4) Sales Market Share by Type (2015-2020)
6.4 Japan Lomustine (CAS 13010-47-4) Sales Market Share by Application (2015-2020)

7 Southeast Asia Lomustine (CAS 13010-47-4) Market Facts & Figures
7.2 Southeast Asia Lomustine (CAS 13010-47-4) Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Lomustine (CAS 13010-47-4) Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Lomustine (CAS 13010-47-4) Sales Market Share by Application (2015-2020)

8 India Lomustine (CAS 13010-47-4) Market Facts & Figures
8.2 India Lomustine (CAS 13010-47-4) Sales Market Share by Company (2015-2020)
8.3 India Lomustine (CAS 13010-47-4) Sales Market Share by Type (2015-2020)
8.4 India Lomustine (CAS 13010-47-4) Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Lomustine (CAS 13010-47-4) Business
12.1 Medicon Pharma
12.1.1 Medicon Pharma Lomustine (CAS 13010-47-4) Corporation Information
12.1.2 Medicon Pharma Lomustine (CAS 13010-47-4) Business Overview and Total Revenue
12.1.3 Medicon Pharma Lomustine (CAS 13010-47-4) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Medicon Pharma Lomustine (CAS 13010-47-4) Products Offered
12.1.5 Medicon Pharma Recent Development
12.2 Nanjing Pharma
12.2.1 Nanjing Pharma Lomustine (CAS 13010-47-4) Corporation Information
12.2.2 Nanjing Pharma Lomustine (CAS 13010-47-4) Business Overview and Total Revenue
12.2.3 Nanjing Pharma Lomustine (CAS 13010-47-4) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Nanjing Pharma Lomustine (CAS 13010-47-4) Products Offered
12.2.5 Nanjing Pharma Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Lomustine (CAS 13010-47-4) Corporation Information
12.3.2 Bristol-Myers Squibb Lomustine (CAS 13010-47-4) Business Overview and Total Revenue
12.3.3 Bristol-Myers Squibb Lomustine (CAS 13010-47-4) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Bristol-Myers Squibb Lomustine (CAS 13010-47-4) Products Offered
12.3.5 Bristol-Myers Squibb Recent Development
12.4 NextSource Pharma
12.4.1 NextSource Pharma Lomustine (CAS 13010-47-4) Corporation Information
12.4.2 NextSource Pharma Lomustine (CAS 13010-47-4) Business Overview and Total Revenue
12.4.3 NextSource Pharma Lomustine (CAS 13010-47-4) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 NextSource Pharma Lomustine (CAS 13010-47-4) Products Offered
12.4.5 NextSource Pharma Recent Development
12.5 Zhongfu Pharma
12.5.1 Zhongfu Pharma Lomustine (CAS 13010-47-4) Corporation Information
12.5.2 Zhongfu Pharma Lomustine (CAS 13010-47-4) Business Overview and Total Revenue
12.5.3 Zhongfu Pharma Lomustine (CAS 13010-47-4) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Zhongfu Pharma Lomustine (CAS 13010-47-4) Products Offered
12.5.5 Zhongfu Pharma Recent Development
12.6 Miracalus Pharma
12.6.1 Miracalus Pharma Lomustine (CAS 13010-47-4) Corporation Information
12.6.2 Miracalus Pharma Lomustine (CAS 13010-47-4) Business Overview and Total Revenue
12.6.3 Miracalus Pharma Lomustine (CAS 13010-47-4) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Miracalus Pharma Lomustine (CAS 13010-47-4) Products Offered
12.6.5 Miracalus Pharma Recent Development
12.7 ACTIZA
12.7.1 ACTIZA Lomustine (CAS 13010-47-4) Corporation Information
12.7.2 ACTIZA Lomustine (CAS 13010-47-4) Business Overview and Total Revenue
12.7.3 ACTIZA Lomustine (CAS 13010-47-4) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 ACTIZA Lomustine (CAS 13010-47-4) Products Offered
12.7.5 ACTIZA Recent Development
12.8 Ther Dose
12.8.1 Ther Dose Lomustine (CAS 13010-47-4) Corporation Information
12.8.2 Ther Dose Lomustine (CAS 13010-47-4) Business Overview and Total Revenue
12.8.3 Ther Dose Lomustine (CAS 13010-47-4) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Ther Dose Lomustine (CAS 13010-47-4) Products Offered
12.8.5 Ther Dose Recent Development

13 Lomustine (CAS 13010-47-4) Manufacturing Cost Analysis
13.1 Lomustine (CAS 13010-47-4) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Lomustine (CAS 13010-47-4)
13.4 Lomustine (CAS 13010-47-4) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Lomustine (CAS 13010-47-4) Distributors List
14.3 Lomustine (CAS 13010-47-4) Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のロムスチン市場レポート2020年(Global Lomustine (CAS 13010-47-4) Sales Market Report 2020)]についてメールでお問い合わせはこちらでお願いします。